Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- Justin Pham Started HD Emergently and Switched to PD Posted 11-11-2025
- Strive Health Receives $550 million to Expand Services and Partnerships Posted 10-14-2025
- NIDDK Awards $3.9M 5-year Grant to Study Home Dialysis Quality of Life Posted 10-14-2025
- Simergent’s Archimedes™ PD Machine FDA-approved for Home and In-center Use Posted 10-14-2025